| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/08/2011 | CN102085382A Special sterilizing medical ultrasound couplant for ophthalmology and preparation method thereof |
| 06/08/2011 | CN102085381A Ferroferric oxide-silicon dioxide-thymine nanoparticles and preparation method and application thereof |
| 06/08/2011 | CN102085380A Preparation method of nano magnetic particles for detection and treatment of coronary heart diseases |
| 06/08/2011 | CN102085379A Medicinal barium sulfate micelle |
| 06/08/2011 | CN101460199B Systems and methods for cell measurement utilizing ultrashort t2* relaxometry |
| 06/07/2011 | US7955602 Annexin proteins and autoantibodies as serum markers for cancer |
| 06/07/2011 | CA2637215C Oral dtpa for radionuclide chelation |
| 06/07/2011 | CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 06/07/2011 | CA2322954C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 06/04/2011 | CA2685580A1 Mag-b |
| 06/03/2011 | WO2011066182A2 Socs3 inhibition promotes cns neuron regeneration |
| 06/03/2011 | WO2011064577A1 Contrast agents for medical microwave imaging |
| 06/03/2011 | WO2011063507A1 Brain tumor targeting peptides and methods |
| 06/03/2011 | WO2011044050A3 Genetically modified mice and engraftment |
| 06/03/2011 | WO2011011384A3 Synthesis of dendrimer conjugates |
| 06/03/2011 | WO2010063491A8 Transport-mediating colloidal pharmaceutical compounds |
| 06/03/2011 | CA2781318A1 Brain tumor targeting peptides and methods |
| 06/03/2011 | CA2779875A1 Socs3 inhibition promotes cns neuron regeneration |
| 06/02/2011 | US20110130580 Use of buckysome or carbon nanotube for drug delivery |
| 06/02/2011 | US20110129425 Process for preparing a pharmaceutical formulation of contrast agents |
| 06/02/2011 | US20110129424 Fluorinated polymers and associated methods |
| 06/02/2011 | US20110129423 Anticancer compounds and screening method |
| 06/02/2011 | US20110129422 Viscous Terpolymers as Drug Delivery Platform |
| 06/02/2011 | US20110129421 Matrix metalloprotease targeting nucleic acids |
| 06/02/2011 | US20110129420 Materials and methods for biological imaging |
| 06/02/2011 | US20110129417 Administrable compositions |
| 06/02/2011 | US20110129415 Novel antibody and use in diagnosis and therapy of arthropathies |
| 06/02/2011 | US20110129413 Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells In Vivo |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2327396A2 Charged lipoprotein complexes and their uses |
| 06/01/2011 | EP2327395A1 Process for the preparation of gadobenate dimeglumine complex in a solid form |
| 06/01/2011 | EP2326383A1 Transdermal delivery in small animals or humans |
| 06/01/2011 | EP2326352A2 Method for detecting dysplasia |
| 06/01/2011 | EP2326348A1 Active particles for bio-analytical applications and methods for preparation thereof |
| 06/01/2011 | CN102083471A Novel mixed ligand core/shell iron oxide nanoparticles for inflammation imaging |
| 06/01/2011 | CN102083470A Method of determining alanine transaminase (ALT) activity by 13C-MR detection using hyperpolarised 13C-pyruvate |
| 06/01/2011 | CN102078624A Efficient Gd-loaded liposome preparation and preparation method thereof |
| 06/01/2011 | CN102078623A Amorphous state iron-based nano magnetic resonance contrast agent material and preparation method thereof |
| 06/01/2011 | CN102078617A Method for synthesizing mesoporous silica-based nanocomposite embedded with gold nanorods |
| 06/01/2011 | CN102078613A Inhibitors of her3 activity |
| 05/31/2011 | US7951989 Methods of screening agents for activity using teleosts |
| 05/31/2011 | US7951772 Tumor-activated prodrug compounds and treatment |
| 05/31/2011 | US7951453 hydrophilic interior core containing metal or semiconductor and and hydrophobic ligand encapsulated micelle |
| 05/31/2011 | US7951402 Drug delivery particle |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | CA2393232C Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
| 05/26/2011 | WO2011063356A2 Rare earth-doped up-conversion nanoparticles for therapeutic and diagnostic applications |
| 05/26/2011 | WO2011062217A1 Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same |
| 05/26/2011 | WO2011061541A1 Liposome nanoparticles for tumor magnetic resonance imaging |
| 05/26/2011 | WO2011061341A1 Process for the preparation of gadobenate dimeglumine complex in a solid form |
| 05/26/2011 | WO2011039535A3 Micellar compositions for use in biological applications |
| 05/26/2011 | WO2011036191A3 Gold –coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents |
| 05/26/2011 | WO2011008996A3 Peptides whose uptake in cells is controllable |
| 05/26/2011 | WO2011005609A3 Imaging gastrointestinal volumes and motility |
| 05/26/2011 | US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging |
| 05/26/2011 | US20110126297 Transgenic animal with monocyte chemotactic protein 1 promoter |
| 05/26/2011 | US20110125079 Echogenic Polymer Microcapsules and Nanocapsules and Methods for Production and Use Thereof |
| 05/26/2011 | US20110124965 Chemiluminescence enhanced detection |
| 05/26/2011 | US20110123602 Molecular lymphatic mapping of sentinel lymph nodes |
| 05/26/2011 | US20110123552 Agonistic binding molecules to the human OX40 receptor |
| 05/26/2011 | US20110123458 Polymer-metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
| 05/26/2011 | US20110123457 Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization |
| 05/26/2011 | US20110123456 Hollow biodegradable nanospheres and nanoshells for delivery of therapeutic and/or imaging molecules |
| 05/26/2011 | US20110123455 Rational design of regenerative medicine products |
| 05/26/2011 | US20110123454 Method for modulating appetite |
| 05/26/2011 | US20110123453 Polyoxazolines with Inert Terminating Groups, Polyoxazolines Prepared from Protected Initiating Groups and Related Compounds |
| 05/26/2011 | US20110123452 Metal oligomers and polymers and their use in biology and medicine |
| 05/26/2011 | US20110123451 Method for Cell Delivery Using Targeted Liposomes Associated with a Hemolysin |
| 05/26/2011 | US20110123450 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical application |
| 05/26/2011 | US20110123449 Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 05/26/2011 | US20110123448 Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein |
| 05/26/2011 | US20110123447 Method of providing human tumor-specific antibodies |
| 05/26/2011 | US20110123446 Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates |
| 05/26/2011 | US20110123445 Treatment monitoring |
| 05/26/2011 | US20110123443 Pancreatic beta-cell mass biomarker |
| 05/26/2011 | US20110123442 Tumor specific antibodies and uses therefor |
| 05/26/2011 | US20110123438 Universal anchor peptide for nanoparticles |
| 05/26/2011 | CA2781718A1 Process for the preparation of gadobenate dimeglumine complex in a solid form |
| 05/26/2011 | CA2781329A1 Magnetic iron oxide fine particles, and magnetic particle-containing water dispersion and process for producing the same |
| 05/25/2011 | EP2325642A1 Use of multimodality nanostructures to detect target substances |
| 05/25/2011 | EP2325236A1 Dendritic polymers with enhanced amplification and interior functionality |
| 05/25/2011 | EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 05/25/2011 | EP2324362A1 Dye application for confocal imaging of cellular microstructure |
| 05/25/2011 | EP2323696A1 Optical method for the detection of alzheimer's disease |
| 05/25/2011 | EP2323636A1 Chelating amphiphilic polymers |
| 05/25/2011 | CN102070747A Polymer for fluorescein angiogram and isotope angiogram |
| 05/25/2011 | CN102068707A Traditional Chinese medicine contrast medium adjuvant used for B ultrasonic and preparation method thereof |
| 05/25/2011 | CN102068706A Preparation method of silicon dioxide (SiO2) ultrasonic imaging radiography material |
| 05/25/2011 | CN102068705A Carbon nanotube/chitosan/magnetic ferrite nanoparticle composite material, and preparation method and application thereof |
| 05/25/2011 | CN102068704A Dental plaque detection liquid |
| 05/25/2011 | CN102068693A Application of complete Freund adjuvant (CFA) to preparation of tibia inflammatory pain model |
| 05/25/2011 | CN101693114B Preparation method and application of trimanganese tetroxide nano-radiography material with target function |
| 05/24/2011 | US7947443 DNA and RNA conformational switches as sensitive electronic sensors of analytes |
| 05/24/2011 | US7947307 Methods and compositions for imaging |
| 05/24/2011 | US7947256 Biocompatible fluorescent imaging agents |
| 05/24/2011 | US7947255 Fluorescent substrates for neurotransmitter transporters |
| 05/24/2011 | US7947254 Method of detecting a neuromyelitis optica specific-autoantibody by an antigenic aquaporin-4 polypeptide |
| 05/24/2011 | US7947253 Perturbed membrane-binding compounds and methods of using the same |
| 05/24/2011 | CA2673620C Biopsy site marker and process and apparatus for applying it |
| 05/24/2011 | CA2649247C Diagnostic for evaluating gastric evacuation function and/or small intestinal absorption function |